Finch Therapeutics Group Inc (FNCH)

개요 뉴스 가격 이력 Financials 토론 예측 주식 분할

Relative Volume:

Finch Therapeutics Group Inc Stock (FNCH) Company Profile

Finch Therapeutics Group Inc

Healthcare (1172)

Biotechnology (672)

최신 SEC 제출 서류

FNCH's Discussions on Twitter

FNCH을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
FNCH Finch Therapeutics Group Inc	13.70	0	614.00K	-76.35M	-31.51M	-47.63
ONC Beigene Ltd Adr	238.31	25.61B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	446.00	114.83B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.26	41.82M	0	0	0	0.00
REGN Regeneron Pharmaceuticals Inc	603.26	66.38B	14.09B	4.50B	2.96B	39.28
VRNA Verona Pharma Plc Adr	75.61	6.36B	0	-153.72M	-103.81M	-2.00

Finch Therapeutics Group Inc Stock (FNCH) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2022-08-09	개시	H.C. Wainwright	Buy
2021-04-13	개시	BofA Securities	Buy
2021-04-13	개시	Evercore ISI	Outperform
2021-04-13	개시	Jefferies	Buy

Finch Therapeutics Group Inc 주식(FNCH)의 최신 뉴스

Finch Therapeutics Group Inc (FNCH) 재무 분석

Finch Therapeutics Group Inc (FNCH)

Finch Therapeutics Group Inc Stock (FNCH) Company Profile

FNCH을(를) 다른 주식과 비교

Finch Therapeutics Group Inc Stock (FNCH) Upgrades & Downgrades

Finch Therapeutics Group Inc 주식(FNCH)의 최신 뉴스

Fecal Transplant Treatment Market: Manufacturer Capacity, Output, Sales, Competition Analysis Report 2025 - openPR.com

Live Biotherapeutic Product Market Growth Driven by Digestive - openPR.com

Critical Review: Enfusion (NYSE:ENFN) vs. Duos Technologies Group (NASDAQ:DUOT) - Defense World

Life360 (NASDAQ:LIF) versus Workday (NASDAQ:WDAY) Head-To-Head Comparison - Defense World

Head to Head Contrast: Crimson Wine Group (OTCMKTS:CWGL) versus Eastside Distilling (NASDAQ:BLNE) - Defense World

Finch Therapeutics Group (NASDAQ:FNCH) and Quince Therapeutics (NASDAQ:QNCX) Head to Head Comparison - Defense World

Clostridium Difficile Infections Clinical Trials 2025: EMA, - openPR.com

Stifel Financial Corp Acquires 1,495 Shares of Iridium Communications Inc. (NASDAQ:IRDM) - Defense World

Dimensional Fund Advisors LP Has $4.56 Million Position in Red River Bancshares, Inc. (NASDAQ:RRBI) - Defense World

Microbiome Therapeutic Market Poised to Reach USD 3,121.8 Million by 2035, Growing at a CAGR of 14.2% - openPR.com

Dimensional Fund Advisors LP Has $10.38 Million Stock Position in Ero Copper Corp. (NYSE:ERO) - Defense World

Raymond James Financial Inc. Takes $554,000 Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World

Calamos Long/Short Equity & Dynamic Income Term Trust (NASDAQ:CPZ) Short Interest Down 15.0% in April - Defense World

Clostridium Difficile Infections Pipeline and Clinical Trials - openPR.com

5 Best Microbiome Companies (May 2025) - Securities.io

Arquitos Capital's Largest Holdings For Q1 2025 - Seeking Alpha

Arquitos Capital Management Q1 2025 Investor Letter - Seeking Alpha

Global Human Microbiome Market: Exploring Technological Innovations Fueling 31% CAGR Growth by 2030 - PharmiWeb.com

Prosperity Bancshares (PB) Expected to Announce Quarterly Earnings on Wednesday - American Banking and Market News

Vanguard Group Inc. Increases Stake in Westrock Coffee (NASDAQ:WEST) - Defense World

Financial Contrast: Kiromic BioPharma (NASDAQ:KRBP) and Finch Therapeutics Group (NASDAQ:FNCH) - Defense World

Clostridium Difficile Infections Pipeline 2025: MOA, ROA, - openPR.com

Rising Prevalence Of Gastrointestinal Disorders Growth In Fecal Microbiota Transplantation (FMT) Market: A ... - WhaTech

Procaps Group (NASDAQ:PROC) Stock Price Down 40.3% – Time to Sell? - Defense World

Finch Therapeutics Group (NASDAQ:FNCH) Stock Price Up 1.5% – Still a Buy? - Defense World

Wickes Group (LON:WIX) Trading Down 0.2% – What’s Next? - Defense World

TechBio and Microbiome (III) - substack.com

Microbiome Disease Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 140+ Companies and 180+ Therapies | DelveInsight - GlobeNewswire

Microbiome Disease Clinical Trial Analysis: Key Insights - GlobeNewswire

(PDF) Global Human Microbiome Market: The Impact of Lifestyle Diseases on the Projected 31% CAGR Growth by 2030 - ResearchGate

Finch Therapeutics Group (NASDAQ:FNCH) Trading Down 0.3% – What’s Next? - Defense World

Innovent Biologics (OTCMKTS:IVBXF) Shares Down 0.2% – Here’s Why - Defense World

Scheid Vineyards (OTCMKTS:SVIN) Stock Price Down 5.3% – What’s Next? - Defense World

Thunderbird Entertainment Group (OTCMKTS:THBRF) Stock Price Down 5.9% – Here’s Why - Defense World

COSCO SHIPPING (OTCMKTS:CICOF) Trading Up 9.7% – Here’s What Happened - Defense World

Clostridium Difficile Infections Clinical Trials and Pipeline - openPR

Ulcerative Colitis Clinical Trials and Drugs 2025: EMA, PDMA, - openPR

Finch Therapeutics: Post-Trial Decision Can Potentially Drive Shares To Trade Higher - Seeking Alpha

Human Microbiome Market Size to Surge to $4.85 Billion by - GlobeNewswire

Arquitos Capital Management Q4 2024 Commentary - Seeking Alpha

B. Riley Analysts Decrease Earnings Estimates for Magnite - Defense World

Liquidity Services (LQDT) Expected to Announce Quarterly Earnings on Thursday - Defense World

Sixth Street Specialty Lending (NYSE:TSLX) Sets New 52-Week High After Analyst Upgrade - Defense World

AptarGroup (ATR) Projected to Post Quarterly Earnings on Thursday - Defense World

Atb Cap Markets Has Bearish Outlook for TSE:KEC Q2 Earnings - Defense World

Research Analysts Set Expectations for Redwire Q2 Earnings - Defense World

Phillips Edison & Company, Inc. (PECO) Projected to Post Earnings on Thursday - Defense World

Lantheus Holdings, Inc. Enters Agreement to Acquire Evergreen TheragnosticsOn January 27, 2025, Lantheus Holdings, Inc. (NASDAQ: LNTH) announced that its subsidiary, Lantheus Medical Imaging, Inc., has entered into a definitive Agreement and Plan of - Defense World

PG&E Co. (NYSE:PCG) Given Average Rating of “Moderate Buy” by Analysts - Defense World

CARGO Therapeutics, Inc. Announces Workforce Reduction and Strategic Shift - Defense World

Sumco (OTCMKTS:SUMCF) Trading Down 2% – Time to Sell? - Defense World

Finch Therapeutics Group Inc (FNCH) 재무 분석

매출

순이익

현금흐름

주당 순 이익

FNCH과 유사한 종목